SCHEMBL14017828

SCHEMBL14017828

CC(C)NC1c2ccccc2CC1O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 5/20 0.48
MMP1 P03956 4/20 0.48
MMP2 P08253 4/20 0.48
MMP8 P22894 4/20 0.48
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45
APH1A Q96BI3 1/20 0.45
PSENEN Q9NZ42 1/20 0.45
NAMPT P43490 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
P2RX7 Q99572 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13167423 1.00 MMP9 (0.48) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL21843955 1.00 MMP9 (0.48) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL7750033 1.00 MMP9 (0.48) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL20131094 1.00 MMP9 (0.48) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL13039794 1.00 MMP9 (0.48) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL20131063 0.84 MMP9 (0.47) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL24946114 0.83 MMP9 (0.43) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL18893525 0.82 MMP9 (0.46) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL18893378 0.82 MMP9 (0.46) MMP9MMP1MMP2MMP8PSEN1
SCHEMBL12380788 0.81 OPRM1 (0.41) MMP9MMP1MMP2MMP8MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7173031-B2 Pyrrolotriazine kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-06 US disclosed
CN-1197070-A Process for preparing optically active phenylglycidyl acid derivative DSM NV (NL) 1998-10-28 CN disclosed